ELISA, LAT & IHC Flashcards

1
Q

What are the principles of indirect ELISA?

A
  • bind/coat antigens onto walls of microtitre plate
  • wash off excess antigen
  • add irrelevant protein
  • add patient antibodies
  • wash off excess antibody
  • add secondary antibody and a substrate
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Describe bind/coat antigens onto wells of microtitre plate step in indirect ELISA

A
  • typically 96 well plate
  • plate has plastic with high affinity for binding immunoglobulins
  • different plates will bind better to different antigens, usually protein binding plates are used
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Describe addition of irrelevant protein in indirect ELISA

A
  • protein must not interfere with assay
  • gelatine commonly used
  • blocks unbound sites of plate
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Describe addition of patient antibodies in indirect ELISA

A
  • extract from patient serum beforehand
  • if unbound sites not blocked - risk of non-specific binding of patient’s antibody to the plastic
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Describe washing off excess antibody in indirect ELISA

A
  • important to note all types of antibodies will be present so need to remove antibodies not specific to desired disease
  • antibodies left known as primary antibody
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Describe adding secondary antibody and substrate in indirect ELISA

A
  • directed against the 1st antibody
  • coupled to enzyme or fluorophore to allow for visual detection
  • raised for human IgG - able to recognise and bind to
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Describe a positive indirect ELISA result

A

obvious colour change, usually green

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Describe a negative indirect ELISA result

A

no colour or background colour - antigens can have a slight green hint

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Give an example of a common substrate

A

ABTS - green

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How are the colour changes detected in ELISA?

A
  • plate readers common
  • human eyes too much error
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Describe the example of schistosome and ELISA diagnosis

A
  • soluble egg antigen (SEA) ELISA used
  • test validated using eggs present in patient’s faeces/urine that are known to have the disease
  • negative control of people with exposure but not infected
  • control of avg. blood donors
  • negative cutoff value - mean optical density of all tropical negative patients plus 3 standard deviations
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Describe improvements to SEA ELISA

A
  • principles of antigen-antibody binding to detect immunodominant antigens in SEA
  • stacking gel on top and running gel on bottom
  • negative electrode at top - sodium dodecyl sulphate - detergent with negative charge, dragging molecules down to positive electrode
  • transfer gels to nitrocellulose paper
  • add patient serum to see which antibodies it binds to
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the principles for a diagnostic test?

A
  • sensitivity
  • specificity
  • usually a trade off between sensitivity and specificity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Describe sensitivity

A
  • no. people testing positive as a proportion of people that had an infection
  • equation is no. true positives / (no. true positives & false negatives)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Describe specificity

A
  • no. people who give negative results as a proportion of total no. people that don’t have the infection
  • no. true negatives / (no. true negatives & false positives)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the different types of ELISA?

A
  • direct - 1 conjugated antibody
  • indirect - 1 conjugated, 1 unconjugated antibody
  • sandwich - 2 antibodies used to sandwich the antigen
  • competitive
17
Q

Describe a competitive ELISA

A
  • competitive binding process executed by original sample, add in inhibitory antigen and try to outcompete original antigen
  • good for impure samples
  • high specificity
18
Q

Describe LAT

A
  • Latex Agglutination Test
  • antigens coated onto latex beads of pre-determined size
  • if patient has antibodies against antigen - agglutination of latex beads
  • if patient has no antibodies - no agglutination
19
Q

What are the advantages of ELISA?

A
  • multiple samples/replicates per plate - high throughput
  • high sensitivity
  • high specificity
  • flexibility
  • quantitative
20
Q

What are the disadvantages of ELISA?

A
  • laborious, can take up to 2 days
  • specialised equipment
  • trained personnel
  • cold chain - storage of antibodies
  • temporary readouts due to enzyme/substrate reactions
21
Q

Describe the advantages of LAT

A
  • rapid
  • bedside/pen side diagnosis - common in veterinary
  • requires limited specialist equipment/training
22
Q

What are the disadvantages of LAT?

A
  • lower sensitivity
  • misinterpretation of results
  • qualitative/semi-quantitative
23
Q

Describe immunohistochemistry (IHC)

A
  • identification of antigens in tissue sections by antibodies
  • chromogenic IHC
  • fluorescent IHC
24
Q

Describe chromogenic IHC

A
  • antibody conjugated to an enzyme
  • catalyses colour change
  • e.g., smooth muscle actin in breast tissue stained using anti-actin antibodies
25
Q

Describe fluorescent IHC

A
  • antibody tagged with a fluorophore
  • e.g., corneal epithelium stained using anti-cytokeratin 3 & 12 antibodies
26
Q

What are the applications of ELISA, LAT & IHC?

A
  • veterinary and medical diagnostics
  • extensively used in disease staging and prognosis
  • transfusion medicine
  • forensic & autopsy pathology applications
  • fundamental and applied research
  • vaccine development/response